Stocks › BDX
BECTON DICKINSON & CO
BDX·NYSE·
United States·USD
United States·USD$180.16
-0.14 (-0.08%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
BDX
BECTON DICKINSON & CO · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
BDXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of BDX by members of U.S. Congress · 107 on record · 4 in the last 12 months
Whale Activity
Position changes in BDX reported for 2026-09-30 by 3 tracked institutional filers
- Increased0
- New0
- Held0
- Decreased0
- Closed0
- No prior filing3
| Filer | Shares | Value | Change |
|---|---|---|---|
| CACTI ASSET MANAGEMENT LLC | 180.3K | $32.8M | — |
| BENEDICT FINANCIAL ADVISORS INC | 25.3K | $4.5M | — |
| Violich Capital Management, Inc. | 16.5K | $3.0M | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by BDX insiders, by quarter · Form 4
Recent Insider Transactions
2,119 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Feld MichaelEVP, Chief Revenue Officer | Sale | −76 | $183.70 | $14K | Sep 28, 2026 | Form 4 ↗ |
| Feld MichaelEVP, Chief Revenue Officer | Sale | −165 | $188.49 | $31K | Aug 26, 2026 | Form 4 ↗ |
| Polen Thomas E JrChairman, CEO and President · Director | Sale | −4,152 | $185.00 | $768K | Aug 13, 2026 | Form 4 ↗ |
| Goette RolandEVP and President, EMEA | Sale | −2,438 | $180.84 | $441K | Aug 11, 2026 | Form 4 ↗ |
| Feld MichaelEVP, Chief Revenue Officer | Sale | −75 | $157.13 | $12K | Jul 27, 2026 | Form 4 ↗ |
| Feld MichaelEVP, Chief Revenue Officer | Sale | −75 | $152.80 | $11K | Jun 26, 2026 | Form 4 ↗ |
| Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Sale | −1,100 | $145.66 | $160K | Jun 24, 2026 | Form 4 ↗ |
| Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Sale | −1,100 | $151.48 | $167K | Jun 10, 2026 | Form 4 ↗ |
| Polen Thomas E JrChairman, CEO and President · Director | Sale | −2,764 | $146.35 | $405K | Jun 1, 2026 | Form 4 ↗ |
| Polen Thomas E JrChairman, CEO and President · Director | Disposition to issuer | −17.4K | $146.15 | $2.5M | Jun 1, 2026 | Form 4 ↗ |
| Polen Thomas E JrChairman, CEO and President · Director | Option exercise | +20.2K | $126.16 | $2.5M | Jun 1, 2026 | Form 4 ↗ |
| Menziuso PeterEVP and President, BDI | Grant / award | +14.3K | $0.00 | $0 | Jun 1, 2026 | Form 4 ↗ |
| Feld MichaelEVP, Chief Revenue Officer | Sale | −75 | $147.35 | $11K | May 26, 2026 | Form 4 ↗ |
| Roque VitorEVP & Chief Financial Officer | Grant / award | +1,721 | $0.00 | $0 | May 7, 2026 | Form 4 ↗ |
| Feld MichaelEVP, Chief Revenue Officer | Sale | −74 | $151.94 | $11K | Apr 27, 2026 | Form 4 ↗ |
| Neal Shana CarolEVP and Chief People Officer | Tax withholding | −1,146 | $0.00 | $0 | Apr 6, 2026 | Form 4 ↗ |
| Feld MichaelEVP, Chief Revenue Officer | Sale | −75 | $156.83 | $12K | Mar 26, 2026 | Form 4 ↗ |
| Minnix LaneshaEVP and General Counsel | Grant / award | +7,492 | $0.00 | $0 | Mar 16, 2026 | Form 4 ↗ |
| Roque VitorInterim CFO | Grant / award | +931 | $0.00 | $0 | Mar 2, 2026 | Form 4 ↗ |
| Spikner Pamela L.SVP Controller & CAO | Grant / award | +931 | $0.00 | $0 | Mar 2, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding BDX · SEC Form N-PORT
This section is temporarily unavailable, reload in a minute.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
This section is temporarily unavailable, reload in a minute.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming BECTON DICKINSON & CO as client
This section is temporarily unavailable, reload in a minute.
Government Contracts
Federal awards to BECTON DICKINSON & CO · USAspending
This section is temporarily unavailable, reload in a minute.
U.S. Patents
Recent USPTO applications naming BECTON DICKINSON & CO
This section is temporarily unavailable, reload in a minute.
Annual Financials
From BDX's 10-K filings · XBRL
This section is temporarily unavailable, reload in a minute.
Stock Splits
Every split and reverse split in the price history
This section is temporarily unavailable, reload in a minute.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
EDGAR ↗ - 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureJul 22, 2026
EDGAR ↗ - 8-K · Items 7.01Reg FD disclosureMay 29, 2026
EDGAR ↗ - 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationMay 20, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsMay 12, 2026
EDGAR ↗ - 8-K/A · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureMay 7, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
EDGAR ↗
About BECTON DICKINSON & CO
From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersFRANKLIN LAKES, NJ
IncorporatedNJ
SEC CIK0000010795 ↗